Do-Youn Oh
MD, PhD
Professor of Internal Medicine
👥Biography 个人简介
Dr. Do-Youn Oh led the TOPAZ-1 global phase 3 trial establishing durvalumab plus gemcitabine and cisplatin as a first line standard in advanced biliary tract cancer. He directs a highly productive clinical research program in hepatobiliary malignancies. His contributions have defined international practice for combination immunotherapy in biliary tract disease.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Do-Youn Oh 的研究动态
Follow Do-Youn Oh's research updates
留下邮箱，当我们发布与 Do-Youn Oh（Seoul National University Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment